Clinical Trials
Braintumor Website

There are 11 trials:
Facility: UT MD Anderson Cancer Center
NCT Trial Name# of Centers

NCT02844439

  Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma
10

NCT00826241

  Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma
6

NCT00883688

  Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma
6

NCT01737671

  Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study
2

NCT00532064

  Early Detection of Cardiotoxicity During Sunitinib or Sorafenib Chemotherapy Using Cardiac Biomarkers
1

NCT00805376

  Delta-24-RGD for Recurrent Malignant Gliomas
1

NCT01110876

  Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)
1

NCT01490060

  Fosaprepitant in Patients Receiving Ifosfamide-based Regimen
1

NCT01582152

  Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma
1

NCT00555399

  Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)
1

NCT01183663

  Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)
1



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites